Delta Lloyd’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q2
$73.3M Sell
554,400
-767
-0.1% -$97.8K 2.06% 4
2017
Q1
$69.1M Buy
555,167
+3,997
+0.7% +$477K 2.08% 4
2016
Q4
$63.5M Buy
551,170
+50,304
+10% +$5.81M 1.99% 7
2016
Q3
$59.2M Buy
500,866
+24,830
+5% +$3.01M 1.84% 6
2016
Q2
$57.7M Sell
476,036
-10,597
-2% -$1.2M 1.94% 4
2016
Q1
$52.7M Sell
486,633
-50,759
-9% -$5.26M 1.74% 6
2015
Q4
$55.2M Buy
537,392
+32,353
+6% +$3.25M 1.91% 6
2015
Q3
$47.1M Sell
505,039
-49,453
-9% -$4.78M 1.51% 8
2015
Q2
$54M Sell
554,492
-110,020
-17% -$11M 1.68% 9
2015
Q1
$66.8M Buy
664,512
+187,363
+39% +$19.1M 2.08% 10
2014
Q4
$49.9M Buy
477,149
+3,426
+0.7% +$361K 1.48% 25
2014
Q3
$202M Buy
473,723
+115,555
+32% +$12M 1.83% 28
2014
Q2
$37.5M Buy
358,168
+14,201
+4% +$1.44M 1.18% 30
2014
Q1
$33.8M Buy
343,967
+13,457
+4% +$1.25M 1.15% 30
2013
Q4
$30.3M Buy
330,510
+49,992
+18% +$4.61M 1.06% 32
2013
Q3
$24.3M Sell
280,518
-420,948
-60% -$37.8M 0.93% 32
2013
Q2
$60.2M Buy
+701,466
New +$59.5M 2.32% 7

Other funds holding JNJ

Delta Lloyd's JNJ Position: Q2 2017 in Review

Delta Lloyd reduced its Johnson & Johnson (JNJ) stake by 0.14% in Q2 2017, selling an estimated $97.8K and leaving 554,400 shares worth $73.3M. The position accounts for 2.06% of the portfolio, ranked #4.

Delta Lloyd first reported a position in JNJ in Q2 2013 and has held it in 17 quarters since. The position peaked at $202M in Q3 2014. 2,349 funds tracked by Wall St. Rank hold JNJ as of Q2 2017.

  • Delta Lloyd held 554,400 shares of Johnson & Johnson worth $73.3M as of Q2 2017.
  • Delta Lloyd sold 767 Johnson & Johnson shares in Q2 2017, an estimated $97.8K.
  • Johnson & Johnson made up 2.06% of Delta Lloyd's portfolio in Q2 2017, its #4 holding.
  • Delta Lloyd first reported a position in Johnson & Johnson in Q2 2013 and has held it in 17 quarters since.
  • Delta Lloyd's Johnson & Johnson position peaked at $202M in Q3 2014.
  • 2,349 funds tracked by Wall St. Rank held Johnson & Johnson as of Q2 2017.

Based on Delta Lloyd's 13F filing for Q2 2017, filed 9 Aug 2017.